Caroline Solon, VP, Market Access Strategy at Lumanity, was recently featured in ISPOR’s Value & Outcomes Spotlight May/June 2026 edition where she shared her thoughts and insights on one of the most pressing challenges in healthcare today: how to make prescription drugs more affordable across countries and households without compromising the innovation pipeline that brings new treatments to market. With drug prices and national priorities varying widely across the globe, the article explores how HEOR can help healthcare stakeholders walk the drug-pricing tightrope, negotiating lower costs while continuing to support pharmaceutical innovation.
Contact Us
If you’d like more information on how we can help with your market access challenges, please contact us.
